NCT00912717 Pancreatic Adenocarcinoma Gene Environment Risk Study
| NCT ID | NCT00912717 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pittsburgh |
| Condition | Pancreatic Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2004-01 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2004-01 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
After informed consent, participants will be asked to complete a medical/family history questionnaire and provide a blood sample. Some participants may also be asked to provide a urine sample. Individuals undergoing procedures that require collection of biological samples for clinical purposes may have these samples saved for research purposes. Participants will also be asked for their permission for study investigators to access medical records and/or recontact them for updates to their medical and family histories. Data and biospecimens will be stored for potential future research projects.
Eligibility Criteria
Inclusion Criteria: * Histologically confirmed or CT confirmed diagnosis of pancreatic adenocarcinoma * Subjects with abnormal imaging study (CT, MRI, MRCP, EUS) * Control subjects with a clinical diagnosis of a pancreas, liver, or intestinal condition * Control subject with acute pancreatitis * Control subject with chronic pancreatitis * Control subject with biliary obstruction * Control subject with pancreatic cyst * Member of a high risk family (≥ 1 close relative with pancreatic cancer) * Healthy control (without any of the above conditions) Exclusion Criteria: * Under the age of 18 years * Unable to give informed consent * Inability to travel to Pittsburgh for in-person enrollment
Contact & Investigator
Randall E Brand, MD
PRINCIPAL INVESTIGATOR
University of Pittsburgh
Frequently Asked Questions
Who can join the NCT00912717 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pancreatic Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00912717 currently recruiting?
Yes, NCT00912717 is actively recruiting participants. Contact the research team at brandre@upmc.edu for enrollment information.
Where is the NCT00912717 trial being conducted?
This trial is being conducted at Pittsburgh, United States.
Who is sponsoring the NCT00912717 clinical trial?
NCT00912717 is sponsored by University of Pittsburgh. The principal investigator is Randall E Brand, MD at University of Pittsburgh. The trial plans to enroll 10,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.